Strategy Asset Managers’s Charles River Laboratories CRL Stock Holding History

Strategy Asset Managers’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,831	Closed	-$392K	–	261
2022 Q2	$392K	Sell	1,831 -26	-1%	-$6.35K	0.12%	122
2022 Q1	$527K	Buy	1,857 +187	+11%	+$57.7K	0.11%	142
2021 Q4	$629K	Sell	1,670 -1,397	-46%	-$543K	0.16%	113
2021 Q3	$1.27M	Buy	3,067 +2,179	+245%	+$905K	0.28%	73
2021 Q2	$328K	Buy	+888	New	+$297K	0.07%	194

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Strategy Asset Managers's CRL Position: Q3 2022 in Review

Strategy Asset Managers sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,831 shares — an estimated $392K sold.

Strategy Asset Managers first reported a position in CRL in Q2 2021 and held it in 5 quarters. The position peaked at $1.27M in Q3 2021. 584 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

Strategy Asset Managers reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
Strategy Asset Managers sold 1,831 Charles River Laboratories shares in Q3 2022, an estimated $392K.
Strategy Asset Managers first reported a position in Charles River Laboratories in Q2 2021 and held it in 5 quarters.
Strategy Asset Managers's Charles River Laboratories position peaked at $1.27M in Q3 2021.
584 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Strategy Asset Managers's 13F filing for Q3 2022, filed 11 Oct 2022.